Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma

Abstract

Background & AimsHepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Although hepatectomy and transplantation have significantly improved survival, there is no effective chemotherapeutic treatment for HCC and its prognosis remains poor. Sustained activation of telomerase is essential for the growth and progression of HCC, suggesting that telomerase is a rational target for HCC therapy. Therefore, we developed a thymidine analogue pro-drug, acycloguanosyl-5′-thymidyltriphosphate (ACV-TP-T), which is specifically activated by telomerase in HCC cells and investigated its anti-tumour efficacy.MethodsFirst, we verified in vitro whether ACV-TP-T was a telomerase substrate. Second, we evaluated proliferation and apoptosis in murine (Hepa1-6) and human (Hep3B, HuH7, HepG2) hepatic cancer cells treated with ACV-TP-T. Next, we tested the in vivo treatment efficacy in HBV transgenic mice that spontaneously develop hepatic tumours, and in a syngeneic orthotopic murine model where HCC cells were implanted directly in the liver.ResultsIn vitro characterization provided direct evidence that the pro-drug was actively metabolized in liver cancer cells by telomerase to release the active form of acyclovir. Alterations in cell cycle and apoptosis were observed following in vitro treatment with ACV-TP-T. In the transgenic and orthotopic mouse models, treatment with ACV-TP-T reduced tumour growth, increased apoptosis, and reduced the proliferation of tumour cells.ConclusionsACV-TP-T is activated by telomerase in HCC cells and releases active acyclovir that reduces proliferation and induces apoptosis in human and murine liver cancer cells. This pro-drug holds a great promise for the treatment of HCC.

Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis

“…HBV transgenic mouse models are widely used for study of HCC development 28 29 . A strain of HBV transgenic mouse C57BL/6J-Tg(Alb1HBV)44Bri/J is also observed the development of liver fibrosis 14 30 , which was verified in our study.…”

ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression

“…To investigate the exact role of ALKBH5 in HCC, we measured the protein expression of ALKBH5 in four HCC cell lines (HepG2, HUH-7, Sk-hep1, and Hep3b) which often used in liver cancer study 35 , 36 . The results showed that the expression of ALKBH5 was higher in HUH-7 and Sk-hep1 cells and lower in Hep3b cells (Fig.…”

Telomerase reactivation is associated with hepatobiliary and pancreatic cancers

“…Telomerase, a prominent feature of many HCCs, can be used as a therapeutic perk to counter the proliferation of the same tumoral cell. An association with sorafenib is pictured, even if statistically significant results cannot be obtained [50] .…”